Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept for Refractory Heel Enthesitis in Spondylarthropathy
NCT00420303Phase 4Completed
- Sponsor
- Pfizer
- Start
- Jan 2007
- Primary completion
- Sep 2008
- Modality
- Fc-Fusion Proteins
- Countries
- 3
01
Overview
A Phase 4 trial of etanercept in spondyloarthropathy (SpA), enthesitis, sponsored by Pfizer. Started Jan 2007; status: completed.
02
Drugs
etanercept
03
Conditions
spondyloarthropathy (SpA)enthesitis
Beyond the preview
Go deeper on NCT00420303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00420303.